Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Abbott Laboratories (NYSE: ABT)
ABT Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
13.80%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
44.20%
ABT Stock Analysis
ABT
PE Ratio:
24.3
ABT
PEG Ratio:
2.3
ABT
Forward EPS Growth (12 month):
10.60%
ABT
PS Ratio:
3.4
ABT
PSG Ratio:
0.4
ABT
Forward Revenue Growth (12 month):
9.00%
ABT Articles
No data was found